FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study
FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Reduced
F-fluorodeoxyglucose-positron emission tomography (FDG-PET) brain metabolism was recognized as a biomarker of neurodegeneration in the recently proposed ATN framework for Alzheimer's disease (AD) biological definition. However, accumulating evidence suggested it is an independent biomarker, which is denoted as "F" in the very study.
A...
Alternative Titles
Full title
FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1d0ccbe8017e431685fa7ff5d403758b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1d0ccbe8017e431685fa7ff5d403758b
Other Identifiers
ISSN
1758-9193
E-ISSN
1758-9193
DOI
10.1186/s13195-019-0512-1
